A lupus-like butterfly rash following infliximab therapy

Modern Rheumatology

Volumn 15, Issue 3, 2005, Pages 223-224

  Nakamura, Ichiro ^a   Tanno, Makoto ^a   Katsumata, Shin Ichi ^a   Ito, Katsumi ^a  

^a Yugawara Kosei Nenkin Hospital   (Japan)

Author keywords

Butterfly rash; dsDNA antibody; Infliximab; Rheumatoid arthritis; Tumor necrosis factor (TNF )

Indexed keywords

C REACTIVE PROTEIN; DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG ERUPTION; DRUG INFUSION; DRUG TARGETING; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; IMMUNOASSAY; LABORATORY TEST; LETTER; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 22144454314     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-005-0394-x     Document Type: Letter

References (8)

1. Jacob CO, McDevitt HO. Tumor necrosis factor-α in murine autoimmune "lupus" nephritis. Nature 1988;331:356-8.
2. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial; ATTRACT study group. Lancet 1999;354:1932-9.
3. Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 2000;43: 2383-90.
4. Ali Y, Shah S. Infliximab-induced systemic lupus erythematosus. Ann Intern Med 2002;137:625-6.
5. Favalli EG, Sinigaglia L, Varenna M, Arnoldi C. Drug-induced lupus following treatment with infliximab in rheumatoid arthritis. Lupus 2002;11:753-5.
6. Shakoor N, Michalska M, Harris CA, Block JA. Drug-induced systemic lupus erythematosus associated with etanercept therapy (letter). Lancet 2002;359:579-80.
7. Klapman JB, Ene-Stroescu D, Becker MA, Hanauer SB. A lupuslike syndrome associated with infliximab therapy. Inflamm Bowel Dis 2003;9:176-8.
8. Debandt M, Vittecoq O, Descamps V, Le Loët X, Meyer O. Anti-TNF-α-induced systemic lupus syndrome. Clin Rheumatol 2003; 22:56-61.